Cardiac MRI in Ischemic Stroke Study (CaMriSS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Charite University, Berlin, Germany
Sponsor:
Collaborators:
Center for Stroke Research Berlin
Neurology, Charite University, Berlin, Germany
Cardiology and Angiology, Elisabeth Hospital, Essen, Germany
Information provided by (Responsible Party):
Karl Georg Haeusler, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01917955
First received: August 7, 2012
Last updated: May 21, 2014
Last verified: May 2014

August 7, 2012
May 21, 2014
May 2014
December 2015   (final data collection date for primary outcome measure)
Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke. [ Time Frame: < 1 week after ischemic stroke ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01917955 on ClinicalTrials.gov Archive Site
Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke. [ Time Frame: < 1 week after ischemic stroke ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Cardiac MRI in Ischemic Stroke Study
Cardiac MRI in Ischemic Stroke Study

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Overall, 103 patients with acute ischemic stroke detected by brain magnetic resonance imaging will be enrolled.

Stroke
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
103
December 2016
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

Exclusion Criteria:

  • Known atrial fibrillation or cardiac source of embolism
  • Severe aphasia
  • Acute infection or chronic inflammation
  • Severe arteriosclerosis or stenosis of brain-supplying arteries
  • Contraindications for magnetic resonance imaging or transesophageal echocardiography.
Both
18 Years and older
No
Contact: Karl Georg Haeusler, MD +49 30 8445 4244 georg.haeusler@charite.de
Germany
 
NCT01917955
CaMriSS_CSB, EA4/073/10
No
Karl Georg Haeusler, Charite University, Berlin, Germany
Charite University, Berlin, Germany
  • Center for Stroke Research Berlin
  • Neurology, Charite University, Berlin, Germany
  • Cardiology and Angiology, Elisabeth Hospital, Essen, Germany
Study Chair: Prof. Matthias Endres, MD Center for Stroke Research Berlin
Principal Investigator: Karl Georg Haeusler, MD Center for Stroke Research Berlin
Charite University, Berlin, Germany
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP